Treatment of Primary Amoebic Meningoencephalitis (PAM)
Disease Overview
- Primary Amoebic Meningoencephalitis (PAM) has an extremely high mortality rate exceeding 95%, with death typically occurring within 5 days of presentation due to cerebral edema 1
- The clinical presentation mimics bacterial meningitis but does not respond to standard antibiotic therapy 1
- N. fowleri thrives in warm freshwater, with most cases occurring during summer months among individuals with recreational exposure to standing bodies of freshwater 1
Diagnostic Considerations
- Pre-mortem diagnosis is confirmed in only 27% of cases 1
Treatment Regimen
- The most effective treatment for Primary Amoebic Meningoencephalitis (PAM) is a multi-drug regimen that includes amphotericin B (intravenous and intrathecal) combined with miltefosine, along with aggressive supportive care 1, 2
- Amphotericin B (intravenous and intrathecal) combined with other agents 2
- Miltefosine should be added to the regimen as it has been associated with survival in recent cases 1
- Treatment should begin immediately upon suspicion of PAM, as outcome is contingent on early initiation 1
Prognosis and Outcomes
- Before 2013, only three survivors had been reported among 135 known cases 1
- Rapid diagnosis and immediate treatment initiation are the most critical factors for survival 1
Prevention
- Avoid swimming in warm freshwater bodies, particularly during summer months 1
- Avoid nasal water exposure during activities in freshwater 1
- Avoid nasal irrigation with untreated tap water (including neti pots) 1